Flora Growth (FLGC) Expected to Announce Earnings on Monday

Key Points

• Flora Growth (NASDAQ:FLGC) is set to release its Q2 2025 earnings results on August 11, with analysts forecasting a loss of ($0.06) per share and revenues of $11.77 million.
• In its last quarterly report on August 1, Flora Growth reported earnings of ($0.11) per share, missing estimates, despite revenues of $14.80 million, which surpassed analyst expectations.
• The company's stock experienced a 12.8% decline during trading, with shares dropping to $17.35 while maintaining a market cap of $391.59 million.

Flora Growth (NASDAQ:FLGC - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results before the market opens on Monday, August 11th. Analysts expect Flora Growth to post earnings of ($0.06) per share and revenue of $11.77 million for the quarter.

Flora Growth (NASDAQ:FLGC - Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). Flora Growth had a negative return on equity of 261.57% and a negative net margin of 24.86%. The firm had revenue of $14.80 million for the quarter, compared to analysts' expectations of $11.77 million. On average, analysts expect Flora Growth to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Flora Growth Stock Up 7.0%

Flora Growth stock traded up $1.23 during midday trading on Friday, hitting $18.65. 14,640 shares of the stock were exchanged, compared to its average volume of 9,034. Flora Growth has a 52-week low of $15.15 and a 52-week high of $82.29. The stock has a market capitalization of $10.81 million, a price-to-earnings ratio of -0.54 and a beta of 1.97. The business's 50-day moving average price is $24.75 and its 200-day moving average price is $25.92. The company has a quick ratio of 0.67, a current ratio of 0.96 and a debt-to-equity ratio of 0.50.

Wall Street Analyst Weigh In

Separately, Roth Capital set a $30.00 price target on shares of Flora Growth and gave the stock a "buy" rating in a report on Tuesday.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Flora Growth stock. Geode Capital Management LLC raised its stake in Flora Growth Corp. (NASDAQ:FLGC - Free Report) by 1.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 168,572 shares of the company's stock after acquiring an additional 3,015 shares during the quarter. Geode Capital Management LLC owned approximately 29.16% of Flora Growth worth $98,000 as of its most recent filing with the Securities & Exchange Commission. 36.01% of the stock is owned by institutional investors.

Flora Growth Company Profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.